Newsroom

A survey intends to get a clear picture of women’s experiences of medicating while pregnant or breast-feeding Video: Caroline Swain was five weeks pregnant when she was diagnosed with breast cancer. Her health providers didn't initially know what treatments she could take. © The Pregnancy and Medicines Initiative The problem Evidence suggests that up to 95% of the five million women who get pregnant in the EU every year will...

IMI contributed to development of the most promising Ebola vaccines, helping to bring them closer to regulatory approval

Cancer, tuberculosis, and psoriasis are among the topics that could be part of our next Call for proposals, IMI2 – Call 20. Also slated for inclusion in the Call are topics on drugs based on proteins, and vaccines.

IMI Director Pierre Meulien talks about IMI's reaction to the biggest Ebola outbreak in history and how the world is better prepared for future major epidemics.

Applications are now being accepted for EUPATI's 14-month training course for laypeople on medicines research and development.

EU and industry-funded researchers are testing wearable devices, Internet of Things technologies and smartphone apps to transform the lives of people with Alzheimer's disease.

During the month of October we will be taking a look at some of the results of our Ebola-related research projects.

The PHAGO project has identified two genes that might have a significant impact on Alzheimers disease development and progression.

IMI backed three bedside Ebola detection tests that work quickly with minimal equipment or training.